Retrospective Analysis of Once-Daily Versus Twice-Daily Insulin Glargine Dosing in Noncritically Ill Individuals.

Deasiah HogueJennifer Nicole ClementsAdrienne Wright

Published in: Diabetes spectrum : a publication of the American Diabetes Association (2024)

There were no significant differences in efficacy or safety between once-daily and twice-daily insulin glargine in the noncritically ill population. A larger prospective study could confirm these results.

Keyphrases

physical activity
glycemic control
type diabetes
adipose tissue
weight loss
skeletal muscle